Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2025-04-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport
* Zadek described the Zadek Osteotomy option for the treatment of Haglund's syndrome This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the Achilles tendon
\- It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy
* This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open Versus Endoscopic Surgical Management Of Posterior Calcaneal Deformity.
NCT03169465
Reinsertion Achilles Tendon VS Zadek Osteotomy in Insertional Achilles Tendinopathy
NCT06322381
Endoscopic Plantar Fascia Release in Cases of Chronic Resistant Plantar Fasciopathy
NCT05342207
The Role of Dry Needling in Hallux Valgus
NCT06023823
Hallux Abductus Valgus and Extensor Hallux Longus; Treatment by MIS Surgery
NCT06243471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* In 1928, Patrick Haglund described the Haglund syndrome firstly. Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. The soft tissue near the back of the heel can become irritated when the large, bony lump rubs against rigid shoes.
* symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport.
* There are many conservative treatment options to treat it, which contains rest, activity modification, ice, or footwear modification.
* When these treatment for more than 6 months has failed, surgical options will be considered.
* Common surgical methods, including Haglund deformity debridement, endoscopic calcaneoplasty, and Zadek osteotomy (ZO).
* Zadek described the ZO option for the treatment of HS firstly. It was later modified by Keck and ZO is a dorsal closing wedge calcaneal osteotomy that allows the tuberosity of Haglund deformity to be brought forward. This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the AT.
Aim of the work
• This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome.
Patients and Methods
* It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy
* We are aiming in this study to include patients within period between 4/2025 to 10/2025
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients had at least six months of conservative treatment
Exclusion Criteria
2. patients of Haglund's syndrome with AT rupture or degeneration
3. uncontrolled diabetic patients with or without neuropathic joint destruction,
4. Infection such as osteomyelitis.
5. Charcot joint.
6. Peripheral vascular disease
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Kamal Abdelhakeem
Orthopedics resident, Sohag University hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine, Sohag University
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mohamed Kamal Abd Alhakeem Mohamed Kamal Abd Alhakeem, Orthopedics resident, Sohag Un
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohamed Kamal Abd Alhakeem Mohamed Kamal Abd Alhakeem, Orthopedics resident, Sohag Un
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
soh-Med--25-8-2MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.